COVID-19: Indian double mutant strain found in US, Germany, UK, two other nations

The variant has a particularly increased prevalence in Maharashtra, where the strain was present at a very low frequency since October 2020.

Published: 11th April 2021 08:51 AM  |   Last Updated: 11th April 2021 03:29 PM   |  A+A-

A medic administers the COVID-19 vaccine dose to a Japanese woman during a vaccination drive at IMT Industrial Association office, at Manesar in Gurugram district. (Photo | PTI)

NEW DELHI: An Indian variant of the coronavirus with two key mutations, now known as ‘B.1.617’, has been detected in the US, Germany, the UK, Australia and Singapore and enhancing viral replication.

An analysis by experts shows that there are 15 genetic variants, including six spike protein variants (that mediates Covid-19 entry into host cells) and two of these six variants are involved in immune escape a s well as increased infectivity.

The double mutant (L452R + E484Q) was announced by the National Centre for Disease Control (NCDC) on March 25 after it was identified in samples of saliva taken from people in Maharashtra, Delhi, and Punjab.

ALSO READ | Record spike of 4,986 COVID-19 cases in MP, tally over 3.32 lakh; lockdown extended till April 19

The variant has a particularly increased prevalence in Maharashtra, where the strain was present at a very low frequency since October 2020.

Emphasizing further genome sequencing and experimental assays to establish how concerning the combination is, Bani Jolly, a geneticist at the Institute of Genomics and Integrative Biology (IGIB), said both mutations are associated with antibody escape, while L452R has also been associated with a modest increase in infectivity.

WATCH:

A recent research paper says that many variants of SARS-CoV-2 that naturally acquire multiple mutations have emerged and emerging mutations can affect viral properties such as infectivity and immune resistance.

The researchers found that two recently emerging mutants — L452R and Y453F — can escape from the restricted cellular immunity.

ALSO READ | Gujarat sees record 5,011 COVID-19 cases in second wave, peak-equalling 49 deaths

“These mutations reinforce the affinity to viral receptor ACE2 (enzyme), and notably, the L452R mutation increases protein stability, viral infectivity and potentially promotes viral replication.

"Our data suggest that the human leukocyte antigen (HLA)-restricted cellular immunity potentially affects the evolution of viral phenotypes, and the escape from cellular immunity can be a further threat of the Covid-19 pandemic,” said the paper.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp